1. 1Cellular Biotechnology Unit, Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
2. 2Molecular Genetics of Angiogenesis Group, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
3. 3Biological Products, Advanced Therapies and Biotechnology, Department of Medicines for Human Use, AEMPS, Madrid, Spain.
4. 4Immunology Laboratory, Centro Nacional de Microbiología, Instituto de Salud Carlos III (ISCIII), Majadahonda, Spain.